Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Puneet Puri

Showing results (71-80 of 120) with videos related to

Pageof 12
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|October 25, 2017
Characterization of body composition and definition of sarcopenia in patients with alcoholic cirrhosis: A computed tomography based studyJaya Benjamin, Varsha Shasthry, Chetan Ramesh Kaal, et al.
Hepatology (Baltimore, Md.)|May 4, 2017
Alcohol abstinence ameliorates the dysregulated immune profiles in patients with alcoholic hepatitis: A prospective observational studyWei Li, Tohti Amet, Yanyan Xing, et al.
Clinical and Translational Gastroenterology|June 19, 2019
Alcohol Abstinence Does Not Fully Reverse Abnormalities of Mucosal-Associated Invariant T Cells in the Blood of Patients With Alcoholic HepatitisWei Li, Edward L Lin, Suthat Liangpunsakul, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|September 19, 2018
Acute Alcoholic Hepatitis: Natural History and Predictors of Mortality Using a Multicenter Prospective StudySpencer Lourens, Dharma B Sunjaya, Ashwani Singal, et al.
Hepatology Communications|February 5, 2024
The RIVET RCT: Rifamycin SV MMX improves muscle mass, physical function, and ammonia in cirrhosis and minimal encephalopathyJasmohan S Bajaj, Andrew Fagan, Edith A Gavis, et al.
Hepatology (Baltimore, Md.)|February 15, 2020
Fecal Microbiome Distinguishes Alcohol Consumption From Alcoholic Hepatitis But Does Not Discriminate Disease SeverityEkaterina Smirnova, Puneet Puri, Mark D Muthiah, et al.
Alimentary Pharmacology & Therapeutics|June 30, 2020
Clinical assessment for high-risk patients with non-alcoholic fatty liver disease in primary care and diabetology practicesZobair M Younossi, Kathleen E Corey, Naim Alkhouri, et al.
Journal of Hepatology|May 14, 2013
Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosisVishwadeep Ahluwalia, James B Wade, Leroy Thacker, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 1, 2015
De novo hepatic steatosis drives atherogenic risk in liver transplantation recipientsMichael O Idowu, Ravi Chhatrala, M Bilal Siddiqui, et al.
JCI Insight|January 8, 2025
Intestinal mucosal mitochondrial oxidative phosphorylation worsens with cirrhosis progression and is ameliorated with fecal microbiota transplantationJing Zeng, Derrick Zhao, Grayson Way, et al.
Pageof 12

Showing results (71-80 of 120) with videos related to

Sort By:
Pageof 12
Liver International : Official Journal of the International Association for the Study of the Liver|October 25, 2017
Characterization of body composition and definition of sarcopenia in patients with alcoholic cirrhosis: A computed tomography based studyJaya Benjamin, Varsha Shasthry, Chetan Ramesh Kaal, et al.
Hepatology (Baltimore, Md.)|May 4, 2017
Alcohol abstinence ameliorates the dysregulated immune profiles in patients with alcoholic hepatitis: A prospective observational studyWei Li, Tohti Amet, Yanyan Xing, et al.
Clinical and Translational Gastroenterology|June 19, 2019
Alcohol Abstinence Does Not Fully Reverse Abnormalities of Mucosal-Associated Invariant T Cells in the Blood of Patients With Alcoholic HepatitisWei Li, Edward L Lin, Suthat Liangpunsakul, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|September 19, 2018
Acute Alcoholic Hepatitis: Natural History and Predictors of Mortality Using a Multicenter Prospective StudySpencer Lourens, Dharma B Sunjaya, Ashwani Singal, et al.
Hepatology Communications|February 5, 2024
The RIVET RCT: Rifamycin SV MMX improves muscle mass, physical function, and ammonia in cirrhosis and minimal encephalopathyJasmohan S Bajaj, Andrew Fagan, Edith A Gavis, et al.
Hepatology (Baltimore, Md.)|February 15, 2020
Fecal Microbiome Distinguishes Alcohol Consumption From Alcoholic Hepatitis But Does Not Discriminate Disease SeverityEkaterina Smirnova, Puneet Puri, Mark D Muthiah, et al.
Alimentary Pharmacology & Therapeutics|June 30, 2020
Clinical assessment for high-risk patients with non-alcoholic fatty liver disease in primary care and diabetology practicesZobair M Younossi, Kathleen E Corey, Naim Alkhouri, et al.
Journal of Hepatology|May 14, 2013
Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosisVishwadeep Ahluwalia, James B Wade, Leroy Thacker, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 1, 2015
De novo hepatic steatosis drives atherogenic risk in liver transplantation recipientsMichael O Idowu, Ravi Chhatrala, M Bilal Siddiqui, et al.
JCI Insight|January 8, 2025
Intestinal mucosal mitochondrial oxidative phosphorylation worsens with cirrhosis progression and is ameliorated with fecal microbiota transplantationJing Zeng, Derrick Zhao, Grayson Way, et al.
Pageof 12